Need 10,000 Daily Steps to Prevent Obesity? It May Depend on Genetics Current recommendations may underestimate activity needs for people with high genetic risk Mar 27, 2024
FDA Approves First-Ever Drug for Serious Liver Condition Resmetirom indicated for NASH patients with liver scarring Mar 14, 2024
Online Obesity Program Helped Primary Care Patients Lose Weight Weight regain was less in the groups who participated in 9 months of active maintenance Mar 11, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Wegovy Approved for Major Heart Disease Prevention New indication for patients with obesity or overweight and a history of cardiovascular disease Mar 08, 2024
Obesity Drugs Like Wegovy Are Meant for Long-Term Use, but Some Want to Stop Other patients have been forced to ration or halt doses due to drug costs Mar 08, 2024
One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
Rumors on Kate Middleton's Health Swirl; Alcohol Deaths Surge; 1 in 8 Have Obesity Health news and commentary from around the Web gathered by Ƶ staff Mar 01, 2024
Multimodal Pre-Op Program Aids Knee Replacement Candidates Patients feel better as they wait for surgery; a few find they no longer need it Feb 29, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
Bariatric Surgery Tied to Long-Term Cognitive Benefits Surgical weight loss linked with improved cognitive function, mood, and brain parameters on MRI Feb 12, 2024
Ex-Doctor Charged With Manslaughter; NIH Subpoenaed; Social Cost of Obesity Drugs Health news and commentary from around the Web gathered by Ƶ staff Feb 07, 2024
Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024
Durable Weight Loss Follows Just a Few Injections of Novel Drug Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
U.S. Officials Call for More Programs, Education to Improve Diets in America More research on "gut-brain axis" is also needed Feb 02, 2024
Perioperative Complications Not Deciding Factor Between Two Bariatric Procedures Short-term complications and safety similar for sleeve gastrectomy and RYGB Jan 30, 2024
Increasing BMI in Kids Tied to 100% Fruit Juice Consumption Findings support guidance limiting such beverages in young children, researcher says Jan 16, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
More Kids Getting Their Hands on Nonprescription Weight-Loss Products Almost 10% of kids said they've tried at least one drug or dietary supplement in their lifetime Jan 10, 2024
Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Risk But don't ignore maternal overweight, obesity, and gestational diabetes, study says Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
Here Are the Top Diets for 2024 A familar food plan topped the annual U.S. News rankings Jan 03, 2024
Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers Health news and commentary from around the Web gathered by Ƶ staff Dec 14, 2023
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesity Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
Year in Review: Obesity 2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI Dec 01, 2023
Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
Want Lower Obesity Drug Costs? Medicare Holds the Key Medicare coverage will catalyze market competition Nov 17, 2023
Mall Doc Kiosks; Gaza Hospital Stormed; Rationing Semaglutide by Lifestyle Health news and commentary from around the Web gathered by Ƶ staff Nov 16, 2023
And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes Established weight loss and diabetes drug may extend reach to millions more Nov 11, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Excessive Weight Gain in Pregnancy Tied to Earlier Death 50 years of data offer insight into cardiovascular, diabetes, and all-cause mortality Oct 25, 2023
Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kids These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
Obesity Medication Type, Insurance Carrier Linked to Treatment Persistence Amount of weight lost by 6 months also played a role, according to a retrospective cohort study Oct 18, 2023
Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months Oct 17, 2023
